Arbutus Biopharma
ABUS
#6201
Rank
HK$6.50 B
Marketcap
HK$33.81
Share price
-8.47%
Change (1 day)
36.43%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): -HK$2.02

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is -HK$2.04. In 2024 the company made an earnings per share (EPS) of -HK$2.97 an increase over its 2023 EPS that were of -HK$3.44.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.02-32.03%
2024-HK$2.97-13.64%
2023-HK$3.44-4.35%
2022-HK$3.60-44.58%
2021-HK$6.50-17%
2020-HK$7.83-65.4%
2019-HK$22.62138.84%
2018-HK$9.47-22.44%
2017-HK$12.21-78.45%
2016-HK$56.67424.64%
2015-HK$10.80-20.19%
2014-HK$13.5387.96%
2013-HK$7.20-142.59%
2012HK$16.91-342.7%
2011-HK$6.97-25.82%
2010-HK$9.3947.8%
2009-HK$6.35-43.55%
2008-HK$11.26158.91%
2007-HK$4.35-111.88%
2006HK$36.60-552.53%
2005-HK$8.09-71.77%
2004-HK$28.65-14.48%
2003-HK$33.50-8.95%
2002-HK$36.7970.07%
2001-HK$21.6348.01%
2000-HK$14.62-38.54%
1999-HK$23.78-24.6%
1998-HK$31.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-HK$0.47-76.92% Bahamas
NRC Health
NRC
HK$5.48-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA